• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Oxaliplatin-induced ototoxicity in adjuvant setting for colorectal cancer: unusual side effect.

作者信息

Hijri Fatima Zahra, Arifi Samia, Ouattassi Naouar, Mellas Nawfal, El Mesbahi Omar

机构信息

Department of Medical Oncology, Hassan II University Hospital, Route Sidi Hrazem, Fez, 30000, Morocco,

出版信息

J Gastrointest Cancer. 2014 Mar;45(1):106-8. doi: 10.1007/s12029-013-9489-3.

DOI:10.1007/s12029-013-9489-3
PMID:23494572
Abstract
摘要

相似文献

1
Oxaliplatin-induced ototoxicity in adjuvant setting for colorectal cancer: unusual side effect.奥沙利铂在结直肠癌辅助治疗中引起的耳毒性：一种不寻常的副作用。
J Gastrointest Cancer. 2014 Mar;45(1):106-8. doi: 10.1007/s12029-013-9489-3.
2
Oxaliplatin and ototoxicity: is it really safe for hearing?奥沙利铂与耳毒性：其对听力真的安全吗？
Turk J Med Sci. 2014;44(4):586-9. doi: 10.3906/sag-1304-76.
3
Ototoxicity associated with oxaliplatin in a patient with pancreatic cancer.一名胰腺癌患者中与奥沙利铂相关的耳毒性
JOP. 2013 Nov 10;14(6):676-9. doi: 10.6092/1590-8577/1629.
4
Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report.奥沙利铂给药所致急性免疫介导性血小板减少症：一例报告
Tumori. 2010 Jan-Feb;96(1):154-6. doi: 10.1177/030089161009600125.
5
Oxaliplatin-induced haemolytic anaemia.
Lancet. 1999 Oct 2;354(9185):1179-80. doi: 10.1016/s0140-6736(99)03827-1.
6
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.转移性结直肠癌患者中与基于奥沙利铂的化疗相关的严重肝窦阻塞
Ann Oncol. 2004 Mar;15(3):460-6. doi: 10.1093/annonc/mdh095.
7
Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.奥沙利铂诱导的免疫性溶血性贫血：一例报告及文献复习
Anticancer Drugs. 2007 Sep;18(8):973-6. doi: 10.1097/CAD.0b013e3280e9496d.
8
Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.接受奥沙利铂化疗的结直肠癌患者并发嗜酸性粒细胞性肺病
Am J Clin Oncol. 2002 Aug;25(4):388-90. doi: 10.1097/00000421-200208000-00014.
9
Clinical Analysis of Hypersensitivity Reactions to Oxaliplatin Among Colorectal Cancer Patients.结直肠癌患者奥沙利铂过敏反应的临床分析。
Oncol Res. 2018 Jun 11;26(5):801-807. doi: 10.3727/096504017X15139039328978. Epub 2018 Jan 2.
10
Oxaliplatin-based chemotherapy in the management of colorectal cancer.基于奥沙利铂的化疗在结直肠癌治疗中的应用
Expert Rev Anticancer Ther. 2008 Aug;8(8):1223-36. doi: 10.1586/14737140.8.8.1223.

引用本文的文献

1
The "appearing" and "disappearing" ascites in the treatment of colorectal cancer: a case report.结直肠癌治疗中“出现”与“消失”的腹水：一例报告
Front Oncol. 2024 Jun 27;14:1372812. doi: 10.3389/fonc.2024.1372812. eCollection 2024.
2
lncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p.长链非编码RNA MALAT1通过吸附微小RNA-22-3p调节胃癌对奥沙利铂的耐药性。
Onco Targets Ther. 2020 Feb 13;13:1343-1354. doi: 10.2147/OTT.S196619. eCollection 2020.

本文引用的文献

1
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.局部进展期不可切除或交界可切除胰腺癌新辅助 FOLFIRINOX 的回顾性研究。
BMC Cancer. 2012 May 29;12:199. doi: 10.1186/1471-2407-12-199.
2
Oxaliplatin-induced hepatocellular injury and ototoxicity: a review of the literature and report of unusual side effects of a commonly used chemotherapeutic agent.奥沙利铂诱导的肝细胞损伤和耳毒性：文献综述及一种常用化疗药物罕见副作用报告
J Oncol Pharm Pract. 2012 Sep;18(3):355-9. doi: 10.1177/1078155212437901. Epub 2012 Feb 14.
3
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study.
XELOX 联合贝伐珠单抗一线治疗后，XELOX 联合贝伐珠单抗或贝伐珠单抗单药维持治疗转移性结直肠癌患者：III 期 MACRO TTD 研究。
Oncologist. 2012;17(1):15-25. doi: 10.1634/theoncologist.2011-0249. Epub 2012 Jan 10.
4
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.卡培他滨和奥沙利铂辅助治疗 D2 胃切除术后胃癌（CLASSIC）：一项开放标签、随机对照 3 期临床试验。
Lancet. 2012 Jan 28;379(9813):315-21. doi: 10.1016/S0140-6736(11)61873-4. Epub 2012 Jan 7.
5
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.吉西他滨和奥沙利铂联合或不联合厄洛替尼治疗晚期胆道癌的多中心、开放标签、随机、3 期研究。
Lancet Oncol. 2012 Feb;13(2):181-8. doi: 10.1016/S1470-2045(11)70301-1. Epub 2011 Dec 20.
6
Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.顺铂和奥沙利铂的毒性：耳蜗动力学作为耳毒性决定因素的重要性。
J Natl Cancer Inst. 2009 Jan 7;101(1):37-47. doi: 10.1093/jnci/djn418. Epub 2008 Dec 30.
7
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.卡培他滨联合奥沙利铂作为Ⅲ期结肠癌辅助治疗的Ⅲ期试验：对1864例患者的一项计划中的安全性分析
J Clin Oncol. 2007 Jan 1;25(1):102-9. doi: 10.1200/JCO.2006.08.1075.
8
Molecular mechanisms of resistance and toxicity associated with platinating agents.与铂类药物相关的耐药性和毒性的分子机制。
Cancer Treat Rev. 2007 Feb;33(1):9-23. doi: 10.1016/j.ctrv.2006.09.006. Epub 2006 Nov 3.
9
Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate.奥沙利铂在重要的含硫生物化合物和血浆超滤液存在下的降解
Eur J Pharm Sci. 2006 Jul;28(4):278-83. doi: 10.1016/j.ejps.2006.03.001. Epub 2006 Apr 18.
10
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.奥沙利铂、氟尿嘧啶和亚叶酸作为结肠癌的辅助治疗。
N Engl J Med. 2004 Jun 3;350(23):2343-51. doi: 10.1056/NEJMoa032709.